Stimulator of interferon genes: Difference between revisions
Jump to navigation
Jump to search
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
Line 24: | Line 24: | ||
**[[4loj]], [[4lok]] – mSTING CTD + c-di-GMP derivative<br /> | **[[4loj]], [[4lok]] – mSTING CTD + c-di-GMP derivative<br /> | ||
**[[4lol]] – mSTING CTD + chemptherapeutic agent DMXAA<br /> | **[[4lol]] – mSTING CTD + chemptherapeutic agent DMXAA<br /> | ||
**[[4qxo]], [[4qxp]], [[4qxq]], [[4qxr]] – hSTING CTD + chemptherapeutic agent DMXAA<br /> | |||
}} | }} | ||
[[Category:Topic Page]] | [[Category:Topic Page]] |
Revision as of 09:22, 17 June 2015
Stimulator of interferon genes (STING) induces production of type I interferon when cells are infected by viruses, mycobacteria and intracellular parasites. STING recognizes and binds cyclic-di-GMP produced by bacteria and cyclic-GMP AMP (cGAMP) produced by viruses. The C-terminal domain (CTD) (residues 139-379 in human) of STING binds cyclic-di-GMP. STING is a facilitator of innate immune signaling. |
|
3D structures of STING3D structures of STING
(Updated on 17-June-2015